AWE
CELG

Avidian Wealth Enterprises’s Celgene Corp CELG Stock Holding History

Avidian Wealth Enterprises’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-11,177
Closed -$888K – 124
2018
Q2 		$888K Buy
+11,177
New +$928K 0.28% 37
2017
Q4 		– Sell
-1,500
Closed -$219K – 112
2017
Q3 		$219K Buy
+1,500
New +$204K 0.08% 80

Other funds holding CELG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Avidian Wealth Enterprises's CELG Position: Q3 2018 in Review

Avidian Wealth Enterprises sold out of Celgene Corp (CELG) in Q3 2018, closing a stake of 11,177 shares — an estimated $888K sold.

Avidian Wealth Enterprises first reported a position in CELG in Q3 2017 and held it in 2 quarters. The position peaked at $888K in Q2 2018. 1,364 funds tracked by Wall St. Rank hold CELG as of Q3 2018.

  • Avidian Wealth Enterprises reported no remaining Celgene Corp position as of Q3 2018 after selling out during the quarter.
  • Avidian Wealth Enterprises sold 11,177 Celgene Corp shares in Q3 2018, an estimated $888K.
  • Avidian Wealth Enterprises first reported a position in Celgene Corp in Q3 2017 and held it in 2 quarters.
  • Avidian Wealth Enterprises's Celgene Corp position peaked at $888K in Q2 2018.
  • 1,364 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2018.

Based on Avidian Wealth Enterprises's 13F filing for Q3 2018, filed 14 Nov 2018.